Entropion Treatment Market Outlook:
Entropion Treatment Market size was valued at USD 507.6 million in 2025 and is expected to reach USD 980.02 million by 2035, expanding at around 6.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of entropion treatment is assessed at USD 538.67 million.
The growth of the market can be attributed to the increasing number of elderly people, entropion is most commonly found in old people of the age 60 and above. According to the World Bank census, the total share of global population aged above 65 years in 2020 was 9.318%, up from 8.223% in 2015, and this share is expected to further increase in the upcoming years.
In addition to these, factors that are believed to fuel the market growth of entropion treatment include the rise in eye related in the world. Entropion is a condition in which the eyelid folds inwards, and can happen in either eyelid. It can lead to corneal ulcer, retinal infection, and even vision impairment due to corneal damage. According to the data by the World Health Organization (WHO), corneal opacities cause moderate to severe distance vision impairment or loss of vision in over 4.2 million people. Meanwhile, 2.2 billion people suffer from partial or complete blindness globally. The growing awareness regarding optical diseases, and penetration of healthcare services in remote areas worldwide are some of the major factors anticipated to drive the market growth.
